Glenmede Trust Co. NA Has $15,213,000 Stake in Walgreens Boots Alliance, Inc. (WBA)
Glenmede Trust Co. NA held its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 183,826 shares of the pharmacy operator’s stock at the close of the first quarter. Glenmede Trust Co. NA’s holdings in Walgreens Boots Alliance were worth $15,213,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of WBA. Nordea Investment Management AB grew its holdings in Walgreens Boots Alliance by 26.5% during the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after acquiring an additional 1,917,082 shares during the period. Wellington Management Group LLP grew its holdings in Walgreens Boots Alliance by 5.9% during the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after acquiring an additional 1,824,300 shares during the period. TIAA CREF Investment Management LLC grew its holdings in Walgreens Boots Alliance by 22.4% during the first quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock worth $437,632,000 after acquiring an additional 962,959 shares during the period. UBS Asset Management Americas Inc. grew its holdings in Walgreens Boots Alliance by 22.9% during the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock worth $407,982,000 after acquiring an additional 914,888 shares during the period. Finally, Prudential Financial Inc. grew its holdings in Walgreens Boots Alliance by 53.0% during the first quarter. Prudential Financial Inc. now owns 2,211,112 shares of the pharmacy operator’s stock worth $183,632,000 after acquiring an additional 766,200 shares during the period. 60.18% of the stock is currently owned by institutional investors.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 13.50% of the stock is owned by corporate insiders.
Shares of Walgreens Boots Alliance, Inc. (WBA) traded down 0.21% on Friday, reaching $81.39. The company’s stock had a trading volume of 4,523,201 shares. The firm has a market cap of $87.10 billion, a price-to-earnings ratio of 20.55 and a beta of 1.26. The company’s 50 day moving average is $80.80 and its 200-day moving average is $82.15. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.18 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be paid a $0.40 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.97%. Walgreens Boots Alliance’s dividend payout ratio is currently 40.30%.
Walgreens Boots Alliance announced that its board has initiated a stock repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.
ILLEGAL ACTIVITY WARNING: This article was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/10/glenmede-trust-co-na-has-15213000-stake-in-walgreens-boots-alliance-inc-wba.html.
A number of equities analysts recently weighed in on WBA shares. Needham & Company LLC started coverage on Walgreens Boots Alliance in a research report on Tuesday, June 27th. They issued a “hold” rating for the company. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, June 24th. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Friday, July 7th. Credit Suisse Group reiterated a “buy” rating and issued a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Finally, Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $91.81.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.